Table 3. Multivariable regression analysis of AKD stage on 30-day and one-year adverse outcomes.
| Outcomes | AKD stage 1 OR/HR (95%CI) | AKD stage 2–3 OR/HR (95%CI) | ||
|---|---|---|---|---|
| Unadjusteda | Adjusted a | Unadjusteda | Adjusteda | |
| 30-day adverse outcomes | ||||
| PRDb | 7.37 (4.22–12.87) |
6.13 (3.46–10.86) |
160.86 (99.62–259.76) |
143.33 (87.62–234.47) |
| New receipt of RRTb | 6.52 (1.62–26.18) |
4.02 (0.98–16.47) |
39.42 (12.30–126.32) |
18.86 (5.74–62.01) |
| Mortalityc | 1.88 (1.28–2.76) |
1.47 (0.99–2.18) |
4.27 (3.22–5.66) |
2.52 (1.86–3.42) |
| MAKE 30b | 2.97 (2.14–4.11) |
2.36 (1.66–3.36) |
34.70 (26.62–45.24) |
31.35 (23.42–41.98) |
| One-year adverse outcomes | ||||
| Chronic dialysisb | 0.82 (0.09–7.33) |
0.41 (0.04–4.11) |
10.42 (3.56–30.48) |
9.85 (2.85–34.10) |
| Mortalityc | 1.44 (1.09–1.90) |
1.24 (0.93–1.65) |
2.94 (2.40–3.59) |
2.08 (1.67–2.59) |
| Chronic dialysis and mortalityb |
1.45 (1.08–1.96) |
1.21 (0.87–1.69) |
3.56 (2.85–4.45) |
2.68 (2.07–3.48) |
Notes.
- AKD
- acute kidney disease
- OR
- odds ratio
- HR
- hazard ratio
- PRD
- persistent renal dysfunction
- RRT
- renal replacement therapy
- MAKE 30
- Major Adverse Kidney Events within 30 days
a
AKD stage 0 was considered as the reference group.
b
Multivariable logistic regression analysis was performed.
c
Multivariable Cox regression analysis was performed.